Losartan Potassium Tablet, Film Coated
Product Images NDC 82009-042

8 FDA label images from Quallent Pharmaceuticals Health Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 82009-042). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Losapotatab1 (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 01)

Losapotatab1 (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 01)
Chemical structure of Losartan Potassium, depicting its molecular arrangement including the chlorinated ring, tetrazole group, and potassium ion.*
FDA Label Image

Losapotatab2 (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 02)

Losapotatab2 (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 02)
A line graph comparing the percentage of patients with a primary endpoint over study months for Losartan Potassium and Atenolol. The x-axis shows study months from 0 to 66, and the y-axis represents the percentage of patients, ranging from 0 to 16%. The graph includes an annotation of an adjusted risk reduction of 13% with a p-value of 0.021.*
FDA Label Image

Losapotatab3 (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 03)

Losapotatab3 (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 03)
A line graph comparing the percentage of patients experiencing fatal or non-fatal strokes over 66 months between Losartan Potassium and Atenolol. The graph shows two lines: a solid line for Losartan Potassium and a dashed line for Atenolol. The x-axis represents study months from 0 to 66, and the y-axis represents the percentage of patients with strokes, ranging from 0 to 8%. The graph includes an annotation indicating an adjusted risk reduction of 25% with a p-value of 0.001 for Losartan Potassium compared to Atenolol.*
FDA Label Image

Losapotatab (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 04)

Losapotatab (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 04)
A forest plot chart comparing hazard ratios with 95% confidence intervals for Losartan Potassium versus Atenolol. The chart presents primary composite and stroke (fatal/non-fatal) event rates across subgroups such as age, gender, race, ischemic heart disease (ISH), diabetes, and history of cardiovascular disease (CVD). The horizontal axis shows hazard ratio with markers indicating favoring Losartan-K or Atenolol.*
FDA Label Image

Losapotatab5 (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 05)

Losapotatab5 (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 05)
A line chart comparing the percentage of patients with an event over 48 months between Losartan Potassium Tablet and placebo groups. The graph shows a lower event rate for Losartan Potassium with a reported risk reduction of 16.1% and a p-value of 0.022.*
FDA Label Image

Losapotataba (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 06)

Losapotataba (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 06)
Losartan Potassium 25 mg film-coated tablets label for oral use by Quallent Pharmaceuticals Health LLC. The label displays the product name, strength (25 mg), quantity of 1,000 tablets, the NDC number 82009-042-10, manufacturer details, storage instructions, and dosage advisory. It includes a barcode and safety warnings about keeping out of reach of children.*
FDA Label Image

Losapotatabb (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 07)

Losapotatabb (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 07)
Label for Losartan Potassium 50 mg tablets, USP, manufactured by Zydus Lifesciences Ltd. and labeled by Quallent Pharmaceuticals Health LLC. The label states that the package contains 1,000 film-coated oral tablets. It includes storage instructions, dosage reference, and a warning to keep drugs out of reach of children. The NDC number 82009-043-10 and barcode are visible.*
FDA Label Image

Losapotatabc (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 08)

Losapotatabc (4b6c3bfa 4344 4173 820e E6ac6b25bd6f 08)
Losartan Potassium 100 mg film-coated tablets carton label for oral use. The package contains 1,000 tablets and is labeled by Quallent Pharmaceuticals Health LLC. The label includes NDC 82009-044-10, dosage instructions to see the package insert, storage conditions, and manufacturer information from Zydus Lifesciences Ltd, India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.